Clinical Implications of Tumor Agnostic Therapies

Shivaani Kummar

2024 SMR Congress Insights: Key Takeaways of Important Trials in Mel…

Roswell Park Comprehensive Cancer Center

I. Puzanov

Successes and Challenges of Early Drug Development for Brain Metasta…

MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis

A. Drilon

Accelerated Approvals in Oncology: Benefits, Risks, and the Way Forw…

Oncology Data Advisor

J. Mouabbi, R. Maclean, M. Glover

HPV Vaccination: Safety, Efficacy, and Importance

GRACE

P. Romesser

Impact of Chronic Stress on Solid Tumor Growth and Immune Response V…

Ben Switzer

Integrating Germline Pharmacogenomic Testing Into Oncology Care

UNC Lineberger Comprehensive Cancer Center

A. Cipriani

Drug Development in Melanoma: Phase I/II/III vs. Novel Designs

Melanoma Bridge 2023

I. Puzanov

Overview of HIPEC for Nurses and APPs

Total Health

I. Solsky

The Common Sense Movement in Oncology

ecancer

V. Vanderpuye

Drug Development in Melanoma: Why Do We Need Novel Trial Designs?

Melanoma Bridge 2023

M. Khasraw

2023 ASCO® Direct Philadelphia: Complementary & Integrative Therapie…

Total Health

B. DuPree

Drug Targets and Synthetic Vulnerabilities in Sarcoma: Our Experienc…

Masonic Cancer Center, University of Minnesota

D. Largaespada

Exploring Rare Cancers: Challenges & Innovations

Oncology Data Advisor

M. Hadfield, W. Haque, A. O’Sullivan, N. Robert, Z. Su

The Evolution of HIPEC in the Treatment of Cancer

Yale Cancer Center

K. Turaga

Point-of-Care Assessment of Anticancer Drug Dosage for Evalauating T…

Ovarian Cancer Midwest Focus, University of Minnesota

X. Xian

Developing Novel Classes of Therapeutics: Walking a Tightrope Withou…

Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

K. High

2023 ASCO® Direct Philadelphia: Artificial Intelligence in Cancer Ca…

Total Health

A. Loaiza-Bonilla

Understanding the Tumor Microenvironment to Unlock the Key to Oncolo…

Oncology Data Advisor

J. Garcia

Promising New Tool in the Battle Against Cancer-Related Fatigue

Yale Cancer Center

R. Perry